Background: The evidence indicates that vitamin D [25(OH)D] improves glycaemic outcomes in type 2 Diabetes mellitus patients. The outcome measures used to determine the accuracy of this hypothesis are: glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG) and homeostasis model assessment-insulin resistance (HOMA-IR). Methods: We performed a systematic review and meta-analysis which included all previous randomised controlled trial (RCT) studies that assessed the effects of vitamin D on glucose metabolism. We carried out an extensive electronic database search of published and unpublished RCTs, evaluating the association between vitamin D and glycaemic outcomes in type 2 diabetes mellitus patients. We clusion, although vitamin D has been extensively studied in relation to some glycaemic outcomes and some indications that increased plasma vitamin D concentrations might be linked to prevention of T2DM, firm universal conclusions about its benefits cannot be drawn. Further studies with better designed trials and larger sample sizes are needed to draw firmer conclusions.
Introduction
Globally, type 2 diabetes mellitus (T2DM) is shifting in two directions: first, from being predominantly a disease of the affluent toward disadvantaged populations and nations; and second, from being a disease of old age toward exponential growth among young people [1] [2] [3] . Some of the factors associated with these shifting patterns include uneven distribution of health determinants and the unintended consequences of phenomena such as aging populations, growing industrialization, urbanization, and market globalization [4] [5] [6] [7] [8]. While the high-income countries have benefited from these phenomena, the low-income countries have paid the price with their health including increased obesity and its associated co-morbidities [7] [8] . In low and middle-income countries, T2DM has shifted from being the 15 th biggest cause of death in 1990
to the 7 th greatest in 2016 [8] [9] [10] . It has been reported that 80% of people diagnosed with T2DM are from low and middle-income countries [10] .
The growing prevalence of obesity, and particularly childhood obesity, has led to a shift in T2DM to younger populations [3] [6] [11] [12] [13] . The estimate from the International Obesity Task Force indicates that about 155 million school-going children worldwide are obese [14] . It has also been observed that T2DM now accounts for about 45% of new onset diabetes in adolescents, as against 3% about 10 years ago [15] .
New evidence is emerging indicating an association between hypovitaminosis D and insulin resistance amongst T2DM patients [12] [16]- [32] . Studies by researchers including Lips et al. [33] found that in patients with established T2DM
and in the general population, low levels of calcidiol (also known as calcifediol, [46] ; and second, through the regulation of calcium homeostasis through β cell membranes [34] . In this second case, vitamin D deficiency (which alters the extracellular and intracellular β cell calcium pool) will adversely affect insulin secretion [39] [44] .
Vitamin D is present in some diets in micro-quantities, albeit rarely [45] . The major source of vitamin D (over 80%) is endogenous, but this requires ultraviolet B radiation from sunlight to activate its precursor 7-dehydrocholesterol in the skin [45] . The evidence indicates that indoor lifestyles and protection from the sun's rays have led to vitamin D deficiency even in countries with abundant sunlight [45] .
In response to this vitamin D/T2DM theory, several studies have evaluated the effect of vitamin D supplementation on a variety of glycaemic outcomes, including the effect of 25(OH)D on glycosylated haemoglobin (HbA1c) levels, plasma glucose levels and homeostatic model assessment insulin resistance (HOMA-IR). These reported conflicting results. For example, studies have found 25(OH)D to be inversely related to HbA1c levels in diabetes mellitus [19] [28] [31] . Some studies reported a decrease in HbA1c and an increase in insulin sensitivity on vitamin D supplementation [47] . Others, such as Ahmadi et al. [22] , found no significant relationship between vitamin D and levels of HbA1c , while Elkassaby et al. [20] in a study on T2DM patients with vitamin D deficiency observed a slight improvement in glycaemic outcomes measured by plasma glucose.
The few studies that measured the effects of vitamin D on HOMA-IR had varying outcomes. Some showed that vitamin D has a slight improvement effect on HOMA-IR [18] [32] ; others showed that vitamin D supplementation in patients with T2DM did not significantly reduce insulin resistance [17] .
Owing to inconsistencies in these results and because these RCTs suffer the same shortcomings (low statistical power, lack of precision and small sample size), this study will systematically review the effects of vitamin D on glycaemic outcomes in T2DM patients. A systematic review is used because the pooled ef- 
Methods

Search Strategy
We of relevant studies were retrieved, and references within them were followed up ("snowballing") to discover studies missed in the initial search.
We used keywords that followed the PICO guidelines (population, intervene- "ergocalciferol" OR "cholecalciferol" AND "glucose metabolism" AND "glycosylated hemoglobin" AND "randomized controlled trials". The Boolean operators "AND" and "OR" were used to focus the search strategy. The following studies were excluded: non-RCT studies; non-peer-reviewed studies; not enough detail given to judge the rigour of the methodology; studies that included patients with gestational diabetes; studies that included patients with pre-diabetes; studies where the full text cannot be assessed; and studies that compared supplementation of vitamin D with calcium.
Study Selection
Data Extraction and Quality Assessment
Data were extracted in duplicate by four independent reviewers (MAM, AB, EA and AO) [9] . Table 1 shows the data that were abstracted regarding the baseline characteristics of the included studies [9] -author, year of publication, study design, country of study, intervention and comparison, study size, participant age and loss to follow-up. Data were extracted and appraised with reference to methodological quality, outcome measures and predetermined criteria relevant to the research questions. 
Statistical Analysis
The extracted data were analysed using revman. RevMan is statistical software Table 2 presents the data that were extracted analysed using revman 5.1. Heterogeneity was estimated statistically using Chi-squared tests (where P > 0.1 suggested a lack of heterogeneity for continuous variables) and I-squared tests (where I 2 > 75% was regarded as great heterogeneity). In addition, homogeneity was visually assessed using interpretation of forest plots. 
Results
This research hypothesized that vitamin D will effectively improve glucose metabolism in type 2 Diabetes mellitus patients. the 95% confidence interval crosses the line of no effect. Figure 7 and Figure 8 show a single study that compared the effect of vitamin D and non-pharmaceutical intervention (counselling) on glycosylated haemoglobin and blood glucose respectively. Nothing was administered to the control group in this study; however, participants were counselled on how to naturally increase vitamin D levels. The authors thought to separate this study from the studies that compared vitamin D with placebo, since the study has a different comparator which may affect the heterogeneity of the study results. For example, a longitudinal study by Munasinghe et al. [50] found that the mean This study showed that vitamin D supplementation in patients with T2DM did not significantly reduce insulin resistance. Comparably, Seida et al. [49] included six studies that examined the effects of vitamin D supplementation on HOMA-IR in T2DM patients [55] . They also found no significant difference in the vitamin D group compared to the placebo group (MD = −1.46; 95% CI = −4.27 to 1.34).
Discussion
Overall, a lack of consensus on the effect of vitamin D supplementation continues to exist among the intervention studies. The consistent feature amongst all of them is lack of statistical significance. Even systematic reviews that combine several RCTs failed to increase statistical power and estimates of precision [49] [56]. This calls for further research into this issue using larger sample sizes.
Conclusion
In conclusion, although vitamin D has been extensively studied in relation to glycaemic outcomes and indications that increased plasma vitamin D concentrations might be linked to prevention of T2DM, firm universal conclusions about its benefits cannot be drawn. Further studies with better designed trials and larger sample sizes are needed to draw firmer conclusions. 
Limitations of the Study
It is important to note that the major strength of this review is its strict adherence to the methods and guidelines included in the Cochrane handbook of systematic reviews. It also included the most recent RCTs which provide up-to-date evidence. However, it was not without its limitations: the funding for this study only covered the lead researcher's time and did not cover resources; consequently, several studies that looked promising from the reviews of their abstracts were excluded due to limited funds to purchase the full text.
